Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

NanoVibronix Inc

NAOV
Current price
0.65 USD -0.041 USD (-5.94%)
Last closed 0.68 USD
ISIN US63008J1088
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 434 218 USD
Yield for 12 month -36.99 %
1Y
3Y
5Y
10Y
15Y
NAOV
21.11.2021 - 28.11.2021

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas. Address: 969 Pruitt Avenue, Tyler, TX, United States, 77569

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.5 USD

P/E ratio

Dividend Yield

Current Year

+2 283 000 USD

Last Year

+752 000 USD

Current Quarter

+817 000 USD

Last Quarter

+921 000 USD

Current Year

+1 537 000 USD

Last Year

+167 000 USD

Current Quarter

+428 000 USD

Last Quarter

+664 000 USD

Key Figures NAOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -2 253 000 USD
Operating Margin TTM -82.5 %
PE Ratio
Return On Assets TTM -29.57 %
PEG Ratio
Return On Equity TTM -140.59 %
Wall Street Target Price 10.5 USD
Revenue TTM 3 373 000 USD
Book Value 1.02 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 177.9 %
Dividend Yield
Gross Profit TTM 167 000 USD
Earnings per share -1.29 USD
Diluted Eps TTM -1.29 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -83.49 %

Dividend Analytics NAOV

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NAOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 09.02.2023
Dividend Date

Stock Valuation NAOV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.1167
Price Sales TTM 0.4252
Enterprise Value EBITDA 0.4288
Price Book MRQ 0.5048

Financials NAOV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NAOV

For 52 weeks

0.46 USD 1.55 USD
50 Day MA 0.59 USD
Shares Short Prior Month 15 071
200 Day MA 0.76 USD
Short Ratio 2.1
Shares Short 515 223
Short Percent 19.39 %